NCT05417581 (OxMiTiAd) is a NA clinical trial of adipose surgery in Digestive Organs--Cancer, sponsored by University Hospital, Clermont-Ferrand.

Who is sponsoring NCT05417581?

NCT05417581 is sponsored by University Hospital, Clermont-Ferrand.

What drugs are being tested in NCT05417581?

Interventions in NCT05417581: adipose surgery.

What condition does NCT05417581 study?

NCT05417581 studies Digestive Organs--Cancer, Bariatric Surgery Candidate, Parietal Region Trauma.

Is NCT05417581 still recruiting?

NCT05417581 is currently terminated. Last updated 2 October 2023.

Last reviewed 2023-10-02 · How we verify

NCT05417581: OxMiTiAd

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mitochondrial Oxygraphy on Subcutaneous and Peri-visceral Adipose Tissue: Influence of Body Composition

Terminated NA Last updated 2 October 2023

What this trial tests

NA trial testing adipose surgery in Digestive Organs--Cancer in 67 participants. Terminated before completion.

Timeline

14 April 2021

Primary endpoint
12 April 2023

12 April 2023

Quick facts

Lead sponsor	University Hospital, Clermont-Ferrand
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	67
Start date	14 April 2021
Primary completion	12 April 2023
Estimated completion	12 April 2023
Sites	1 location across France

Drugs / interventions tested

adipose surgery

Conditions studied

Digestive Organs--Cancer — all drugs for Digestive Organs--Cancer →
Bariatric Surgery Candidate — all drugs for Bariatric Surgery Candidate →
Parietal Region Trauma — all drugs for Parietal Region Trauma →

Sponsor

University Hospital, Clermont-Ferrand

Who can join

18 and older, any sex, with Digestive Organs--Cancer or Bariatric Surgery Candidate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to adapt the oxygraphy technique on human adipocytes and to characterize respiration measurements according to patients' body mass index and white adipose tissue localization (subcutaneous vs visceral).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University Hospital, Clermont-Ferrand trials

Trials by the same sponsor.

NCT07179276 — Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock · NA · recruiting
NCT07476768 — PAINDYS_Characterizing Pain in Fibrous Dysplasia of Bone/McCune-Albright Syndrome: an Exploratory Pilot Study · NA · not yet recruiting
NCT07439146 — Risk of Pneumonia in Intubated Patients in Emergency Situations · not yet recruiting
NCT07427537 — Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients · NA · recruiting
NCT07330856 — Evaluation of Treatments for Dry or Productive Cough · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05417581 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Clermont-Ferrand
Last refreshed: 2 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05417581.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing